ADC Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	335	137	301	1,550	2,270	-
Market Cap Growth	135.17%	-54.63%	-80.59%	-31.71%	-	-
Enterprise Value	223	-19	92	1,223	1,946	-111
PE Ratio	-	-0.57	-1.91	-6.74	-9.22	-
PS Ratio	4.88	1.96	1.43	45.70	-	-
PB Ratio	-1.91	-0.92	3.79	9.33	6.77	-
P/FCF Ratio	-2.36	-1.12	-2.17	-6.71	-13.44	-
P/OCF Ratio	-2.40	-1.15	-2.18	-6.81	-13.51	-
EV/Sales Ratio	3.26	-0.28	0.44	36.07	-	-47.23
EV/EBITDA Ratio	-1.92	0.13	-0.78	-5.31	-8.14	0.97
EV/EBIT Ratio	-1.87	0.12	-0.76	-5.25	-8.07	0.95
EV/FCF Ratio	-1.65	0.16	-0.66	-5.30	-11.52	0.90
Debt / Equity Ratio	-0.63	-0.83	1.48	0.84	0.34	0.05
Debt / EBITDA Ratio	-0.91	-0.81	-1.00	-0.61	-0.48	-0.04
Debt / FCF Ratio	-0.78	-1.01	-0.84	-0.60	-0.68	-0.04
Quick Ratio	4.09	4.49	4.87	6.72	10.86	5.79
Current Ratio	4.61	4.97	5.31	7.10	11.14	6.15
Asset Turnover	0.17	0.16	0.40	0.06	0	0.02
Interest Coverage	-2.83	-3.34	-3.27	-12.71	-48.93	-741.96
Return on Equity (ROE)	224.20%	554.00%	-136.00%	-102.80%	-110.30%	-98.10%
Return on Assets (ROA)	-55.50%	-53.40%	-29.60%	-42.20%	-75.60%	-80.80%
Return on Capital (ROIC)	206.88%	655.06%	-62.67%	-85.59%	-48.66%	-102.76%
Earnings Yield	-67.86%	-175.80%	-52.21%	-14.84%	-10.85%	-
FCF Yield	-46.84%	-89.28%	-46.19%	-14.90%	-7.44%	-
Buyback Yield / Dilution	-2.16%	-4.55%	-1.84%	-8.21%	-6.04%	-
Total Shareholder Return	-2.16%	-4.55%	-1.84%	-8.21%	-6.04%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).